The initial national results of the RECAP survey

 

The initial national results of the RECAP survey

Tendances n° 54, OFDT, 4 p.
June 2007

The data presented in this issue of Tendances have been collected as part of the RECAP survey (Recueil commun sur les addictions et les prises en charges/ Joint Report on Drug Addiction and Drug Treatment) carried out in 2005 at a national level for the first time. These concern the characteristics of patients welcomed that particular year in specialised drug-treatment centres (CSSTs) and alcohol treatment centres (CCAAs).
In 2005, the patient types welcomed by the CCAAs were far more uniform than those seen by the CSSTs. For a long while now, the latter have dealt with patients involved in polydruguse and consequently in a wide range of consumption practices, which require lengthy descriptions. As a result, the description of patients experiencing difficulty with alcohol received by the CCAAs takes up less space in this report.

Authors :
Christophe Palle, Laure Vaissade

Download the PDF file (458 Ko)

 

 

 

 

 

 

 

 

 

Drugs in Europe


2021 EMCDDA European Drug Report

COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?

These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.

  Statistical Bulletin 2021

The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..

The European Union and the drug phenomenon

miniFAQDrugsEurope.jpgThe European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.